Study Stopped
Due to funding and Covid-19 pandemic
CFTR Related Pancreatitis Study
Assessing CFTR Function in Patients With CFTR Related Pancreatitis Using a Novel Sweat Test
1 other identifier
interventional
N/A
0 countries
N/A
Brief Summary
The main causes of acute recurrent pancreatitis (ARP) or chronic pancreatitis (CP) in children are defects in genes that have been associated to pancreatitis. Among these gene defects CFTR gene mutations are commonly found, 34% ARP and 23% CP . Since not every CFTR gene mutations clinically manifest, just identifying these CFTR gene mutations may not help to establish a clear role of this defect in the etiology of the individual ARP/CP. The novel beta-adrenergic sweat secretion test is a very sensitive test to detect small abnormalities in CFTR function in form of a linear gene-function relation. By identifying even mild CFTR defects, in future will help in finding the role of CFTR modulators and providing treatment to these patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Feb 2021
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 16, 2020
CompletedFirst Posted
Study publicly available on registry
February 18, 2020
CompletedStudy Start
First participant enrolled
February 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2021
CompletedJuly 16, 2021
July 1, 2021
Same day
February 16, 2020
July 12, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Assessment of CFTR function using the Beta Adrenergic Sweat Secretion Test
CFTR function assessment of patients with acute recurrent or chronic pancreatitis by using Beta adrenergic sweat test.
60 mins
Study Arms (1)
Interventional Arm
EXPERIMENTALAll patients consented to study will undergo study intervention which is Beta-adrenergic sweat test (Beta sweat test) using evaporimeter. It takes about 60 minutes to complete this test. Once this test is completed, patient will be considered to have completed the study.
Interventions
In Beta Sweat Test - sweat secretion will be stimulated by injecting a series of drugs within the skin surface. Small needles will be used to inject minute amounts of each drug. Before and after each skin injection, the skin will be cleaned using an alcohol swab. 1. Two sensor probes will be strapped to the forearm with rubber bands in position just above the injection site. 2. Under the first probe, injection atropine will be given in one small area of the skin. 3. Under the second probe, first injection carbachol will be given in one small area of the skin. 4. Next, at the second probe area, the normal sweating will be stopped for awhile by injecting a drug called atropine. 5. Lastly, beta-adrenergic sweating will be stimulated by injecting a combination of the following drugs: atropine, isoproterenol, and aminophylline (β-cocktail). Using probes, all sweat rate readings will be recorded.
Eligibility Criteria
You may qualify if:
- Age : 4 years and older
- Diagnosis: Acute recurrent pancreatitis or chronic pancreatitis
- History: at least one of the following:
- Carry one or two CFTR mutations
- Borderline sweat chloride levels
- Has Family History of CF
- Has had positive CF Newborn screening
You may not qualify if:
- Pregnant females: will be excluded at screening.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- The Hospital for Sick Childrenlead
- The National Pancreas Foundationcollaborator
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor and Senior Associate Scientist
Study Record Dates
First Submitted
February 16, 2020
First Posted
February 18, 2020
Study Start
February 1, 2021
Primary Completion
February 1, 2021
Study Completion
February 1, 2021
Last Updated
July 16, 2021
Record last verified: 2021-07